Variant report
Variant | esv3403091 |
---|---|
Chromosome Location | chr2:52099350-52130016 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | 2:51745267-51754233..2:52106672-52112664 | GM12878 | blood: | |
2 | 2:51664217-51674289..2:52100874-52104046 | H1-hESC | embryonic stem cell: | embryo |
3 | 2:51785137-51786126..2:52106672-52112664 | GM12878 | blood: | |
4 | chr2:52097711..52099315-chr2:52104533..52106401,2 | K562 | blood: | |
5 | 2:51664217-51674289..2:52112664-52117037 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139373991 | chr2:52107022-52107023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562164544 | chr2:52107071-52107072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185050585 | chr2:52107111-52107112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11125392 | chr2:52107116-52107117 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
5 | rs564846629 | chr2:52107137-52107138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs117769133 | chr2:52107162-52107163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138374339 | chr2:52107191-52107192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs28965795 | chr2:52107215-52107216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs17868279 | chr2:52107220-52107221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs13033522 | chr2:52107242-52107243 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs369711918 | chr2:52107243-52107244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28948369 | chr2:52107249-52107250 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs551478551 | chr2:52107279-52107280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566795996 | chr2:52107290-52107291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373406031 | chr2:52107293-52107294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533804164 | chr2:52107323-52107324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555538366 | chr2:52107334-52107335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573472306 | chr2:52107340-52107341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542351865 | chr2:52107361-52107362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188984213 | chr2:52107362-52107363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555874851 | chr2:52107367-52107368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114388598 | chr2:52107398-52107399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145161062 | chr2:52107412-52107413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs559854520 | chr2:52107424-52107425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573486845 | chr2:52107442-52107443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550984190 | chr2:52107445-52107446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540543451 | chr2:52107474-52107475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs137937746 | chr2:52107495-52107496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17868280 | chr2:52107502-52107503 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs551177311 | chr2:52107503-52107504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181669637 | chr2:52107541-52107542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533454134 | chr2:52107567-52107568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370586345 | chr2:52107601-52107602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184603609 | chr2:52107630-52107631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547333912 | chr2:52107634-52107635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140628173 | chr2:52107691-52107692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566704241 | chr2:52107771-52107772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534114461 | chr2:52107793-52107794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149453921 | chr2:52107795-52107796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567207826 | chr2:52107817-52107818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374829094 | chr2:52107859-52107860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189876743 | chr2:52107866-52107867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs180674575 | chr2:52107876-52107877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72880549 | chr2:52107884-52107885 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs72880551 | chr2:52107892-52107893 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs141180192 | chr2:52107922-52107923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553459271 | chr2:52107926-52107927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs28965796 | chr2:52107951-52107952 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs542593287 | chr2:52107955-52107956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373677055 | chr2:52107967-52107968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52107000-52108400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:52108000-52108400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr2:52112800-52114200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr2:52115400-52115800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr2:52115600-52115800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr2:52115800-52129400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr2:52116000-52116800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr2:52116800-52117200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr2:52127000-52127400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |